Patent classifications
C
C12
C12N
2795/00
C12N2795/00011
C12N2795/10011
C12N2795/10311
C12N2795/10341
C12N2795/10342
C12N2795/10342
Therapeutic Cancer Vaccine Targeted to HAAH (Aspartyl-[Asparaginyl]-Beta-Hydroxylase
The present invention encompasses a cancer vaccine therapy targeting Aspartyl-[Asparaginyl]-,8-hydroxylase (HAAH). The present invention contemplate bacteriophage expressing HAAH peptide fragments and methods for using said bacteriophage in methods of treating cancer.